FSSAI sources told Business Standard: ''The affidavit has been filed in the court. There is no anomaly in the order issued against Nestle India.'' The authority said without risk assessment and grant of product approval, the product could not be allowed to be sold.
ALSO READ: FSSAI orders recall of four protein supplements
Similarly, the Maharashtra Food and Drugs Authority also strongly defended its action to prohibit the manufacture, storage, distribution and sale of Maggi noodles under section 30 sub clause (a) of clause (2) of the Act. The high court on a petition filed by Nestle India on June 12 had refused to stay the ban but asked both FSSAI and FDA to file their affidavits. The case is slated for hearing on Tuesday. The company has argued that FSSAI’s move was “arbitrary” and “illegal”. An FDA official said its affidavit has mentioned the tests conducted of 20 samples across the state before taking a decision to ban the manufacture and sale of Maggi noodles. He said, according to the reports of the state food analysts, the Maggi noodles manufactured by Nestle India found "unsafe”.
ALSO READ: FSSAI to regulate salt, fat & sugar in eating joints' food